newsfilter
← Latest News
PR Newswire·

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

BIAFBIAFW
  • bioAffinity Technologies, Inc. entered a securities purchase agreement with an institutional investor to sell 8,462,027 shares of common stock or pre-funded warrants, plus warrants for up to 16,924,054 additional shares.
  • The private placement offering is priced at-the-market under Nasdaq rules with a combined effective price of $0.4727 per share and accompanying warrants, or $0.4657 per pre-funded warrant and accompanying warrants.
  • Pre-funded warrants carry an exercise price of $0.007 per share, while the accompanying warrants have an exercise price of $0.4727 per share.
  • All warrants are exercisable following stockholder approval and will expire five years from the date of issuance.
  • Gross proceeds from the offering are estimated at approximately $4.0 million before deducting placement agent fees and other expenses.
  • WallachBeth Capital LLC is acting as the sole placement agent for the transaction.
  • The offering is expected to close on or about August 14, 2026, subject to customary closing conditions.
  • Securities are being sold in a private placement under Section 4(a)(2) of the Securities Act of 1933 or Regulation D, with no registration under the Securities Act.
  • The Company will provide customary registration rights for shares underlying the warrants, subject to definitive transaction document terms.